References
- Willemze R, Cerroni L, Kempf W, et al. Special Report The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas [Internet]. Available from: http://ashpublications.org/blood/article-pdf/133/16/1703/1726414/blood881268.pdf.
- Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-Cell lymphoma. JAMA Dermatol. 2013;149(11):1295.
- Saunes M, Lund Nilsen TI, Johannesen TB. Incidence of primary cutaneous T-cell lymphoma in Norway. British Journal of Dermatology. 2009;160(2):376–379.
- Bradford PT, Devesa SS, Anderson WF, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064–5073.
- Willemze R. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–3785.
- Benner MF, Jansen PM, Vermeer MH, et al. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood. 2012;119(7):1643–1649.
- Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/sézary syndrome: Validation of the revised international society for cutaneous lymphomas/european organisation for research and treatment of cancer staging proposal. J Clin Oncol. 2010;28(31):4730–4739.
- Scarisbrick JJ, Prince HM, Vermeer MH, et al. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol. 2015;33(32):3766–3773.
- Riou-Gotta MO, Fournier E, Mermet I, et al. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003. Leukem Lymphoma. 2008;49(8):1537–1544.
- Imam MH, Shenoy PJ, Flowers CR, et al. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma. 2013;54(4):752–759.
- Morales MM, Putcha V, Evans HS, et al. Survival of mycosis fungoides in patients in the southeast of England. Dermatology. 2005;211(4):325–329.
- Smedby K, Hörstedt A-S, Carlsson T, et al. Nationella kvalitetsregistret för lymfom, Årsrapport nationellt kvalitetsregister, Diagnosår: 2000 - 2020 [Internet]. 2021 [cited 2022 Jan 26]. Available from: https://cancercentrum.se/globalassets/cancerdiagnoser/blod-lymfom-myelom/lymfom/rapporter/lymfom-arsrapport-2000-2020.pdf.
- Eklund Y, Aronsson A, Schmidtchen A, et al. Mycosis fungoides: a retrospective study of 44 swedish cases. Acta Derm Venereol. 2016;96(5):669–673.
- Turesson I, Linet MS, Björkholm M, et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003. Int J Cancer. 2007;121(10):2260–2266.
- Barlow L, Westergren K, Holmberg L, et al. The completeness of the swedish cancer register – a sample survey for year 1998. Acta Oncologica. 2009;48(1):27–33.
- Leinonen MK, Miettinen J, Heikkinen S, et al. Quality measures of the population-based finnish cancer registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–39.
- Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–1231.
- Mårtensson S, Frederiksen BL, de Nully Brown P, et al. Differential case reporting in a national clinical quality database. Quality Management in Health Care. 2012;21(4):278–285.
- Kaufman AE, Patel K, Goyal K, et al. Mycosis fungoides: developments in incidence, treatment and survival. J Eur Acad Dermatol Venereol. 2020;34(10):2288–2294.
- Arboe B, El-Galaly TC, Clausen MR, et al. The danish national lymphoma registry: Coverage and data quality. PLOS One. 2016;11(6):e0157999.
- Santucci M, Biggeri A, Feller AC, et al. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol. 2000;24(1):40–50.